<DOC>
	<DOCNO>NCT01112722</DOCNO>
	<brief_summary>The study identify efficacy Apitox , purify honeybee toxin , 330 patient diagnosed osteoarthritis knee . The subject evaluate relief pain use Western Ontario McMaster Osteoarthritis Index ( WOMAC ) Physician Patient Global Assessments primary efficacy measure relief pain inflammation 12 week treatment period randomization trial . Secondary efficacy improvement mobility Treatment effect compare 2-1 Apitox v active control</brief_summary>
	<brief_title>Apitox , Honeybee Toxin Pain Inflammation Osteoarthritis</brief_title>
	<detailed_description>feasibility Site selection complete US India</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Histamine phosphate</mesh_term>
	<criteria>osteoarthritis one knees stable NSAID none due intolerance woman either post menopausal stable birth control clinically significant disease abnormal laboratory value sign informed consent , communicate effectively , understand comply study requirement serious unstable medical psychological condition know sensitivity honeybee venom , histamine lidocaine history asthma clinically significant ECG abnormality clinically significant laboratory value OOR history drug alcohol abuse history joint injury form inflammatory arthritis</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>honeybee toxin</keyword>
	<keyword>Apitox</keyword>
	<keyword>pain</keyword>
	<keyword>inflammation</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>Apitoxin</keyword>
</DOC>